User profiles for Joseph D. Butner

Joseph D Butner

Assistant Professor, MD Anderson Cancer Center
Verified email at mdanderson.org
Cited by 974

Simulating cancer growth with multiscale agent-based modeling

Z Wang, JD Butner, R Kerketta, V Cristini… - Seminars in cancer …, 2015 - Elsevier
There have been many techniques developed in recent years to in silico model a variety of
cancer behaviors. Agent-based modeling is a specific discrete-based hybrid modeling …

[HTML][HTML] Mathematical modeling in cancer nanomedicine: a review

P Dogra, JD Butner, Y Chuang, S Caserta, S Goel… - Biomedical …, 2019 - Springer
Cancer continues to be among the leading healthcare problems worldwide, and efforts
continue not just to find better drugs, but also better drug delivery methods. The need for …

[HTML][HTML] A mathematical model to predict nanomedicine pharmacokinetics and tumor delivery

P Dogra, JD Butner, JR Ramírez, Y Chuang… - Computational and …, 2020 - Elsevier
Towards clinical translation of cancer nanomedicine, it is important to systematically investigate
the various parameters related to nanoparticle (NP) physicochemical properties, tumor …

Integrated PK-PD and agent-based modeling in oncology

Z Wang, JD Butner, V Cristini, TS Deisboeck - Journal of pharmacokinetics …, 2015 - Springer
Mathematical modeling has become a valuable tool that strives to complement conventional
biomedical research modalities in order to predict experimental outcome, generate new …

Innate immunity plays a key role in controlling viral load in COVID-19: mechanistic insights from a whole-body infection dynamics model

…, J Ruiz-Ramírez, K Sinha, JD Butner… - ACS pharmacology & …, 2020 - ACS Publications
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a pathogen of immense
public health concern. Efforts to control the disease have only proven mildly successful, and …

Mathematical prediction of clinical outcomes in advanced cancer patients treated with checkpoint inhibitor immunotherapy

JD Butner, D Elganainy, CX Wang, Z Wang… - Science …, 2020 - science.org
We present a mechanistic mathematical model of immune checkpoint inhibitor therapy to
address the oncological need for early, broadly applicable readouts (biomarkers) of patient …

[HTML][HTML] Theory and experimental validation of a spatio-temporal model of chemotherapy transport to enhance tumor cell kill

…, YL Chuang, P Dogra, JD Butner… - PLoS computational …, 2016 - journals.plos.org
It has been hypothesized that continuously releasing drug molecules into the tumor over an
extended period of time may significantly improve the chemotherapeutic efficacy by …

Mechanistic modeling identifies drug-uptake history as predictor of tumor drug resistance and nano-carrier-mediated response

J Pascal, CE Ashley, Z Wang, TA Brocato, JD Butner… - ACS …, 2013 - ACS Publications
A quantitative understanding of the advantages of nanoparticle-based drug delivery vis-à-vis
conventional free drug chemotherapy has yet to be established for cancer or other …

Mathematical modeling of cancer immunotherapy for personalized clinical translation

JD Butner, P Dogra, C Chung, R Pasqualini… - Nature computational …, 2022 - nature.com
Encouraging advances are being made in cancer immunotherapy modeling, especially in
the key areas of developing personalized treatment strategies based on individual patient …

A mathematical model for the quantification of a patient's sensitivity to checkpoint inhibitors and long-term tumour burden

JD Butner, Z Wang, D Elganainy… - Nature biomedical …, 2021 - nature.com
A large proportion of patients with cancer are unresponsive to treatment with immune
checkpoint blockade and other immunotherapies. Here, we report a mathematical model of the …